Remote Access to Care, Everywhere, for Parkinson Disease

NCT02144220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 277

Last updated 2017-02-23

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to evaluate the feasibility, efficacy and the value of providing care to individuals with Parkinson disease directly into their homes. The specific aims are:

1. To demonstrate the feasibility of conducting remote evaluations of patients with Parkinson disease nationally;
2. To measure the impact of remote care on each patient's ability to improve his or her quality of life (QoL) and better manage his or her Parkinson disease; and
3. To assess the long-term acceptability to patients in receiving ongoing care remotely via telemedicine.

Conditions

  • Parkinson Disease

Interventions

OTHER

Virtual care visit

Video-conferencing visit with a Parkinson disease specialist

Sponsors & Collaborators

  • Davis Phinney Foundation

    collaborator OTHER
  • University of Rochester

    lead OTHER

Principal Investigators

  • E. Ray Dorsey, MD, MBA · University of Rochester

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-08-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02144220 on ClinicalTrials.gov